NCT00224315View on ClinicalTrials.gov

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

September 30, 2006

Conditions
Schizophrenia, Schizoaffective Disorder
Interventions
DRUG

ziprasidone

DRUG

risperidone

Trial Locations (1)

68159

Central Institute of Mental Health, Department of Psychiatry,, Mannheim

All Listed Sponsors
lead

Central Institute of Mental Health, Mannheim

OTHER

NCT00224315 - Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial | Biotech Hunter | Biotech Hunter